Patents by Inventor Claudio Cavazza

Claudio Cavazza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders
    Patent number: 6515020
    Abstract: A pharmaceutical product which comprises admixed or separately packaged (A) L-Carnitine or an alkanoyl L-canitine and (B) a trihydroxy- or tetrahydroxystilbene such as resveratrol is useful for the prevention and treatment of pathological neuronal or cerebral disorders.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: February 4, 2003
    Assignee: Sigma-Tau HealthScience S.p.A.
    Inventor: Claudio Cavazza
  • Medicament and therapeutical method for treating idiopathic asthenozoospermia
    Publication number: 20030008921
    Abstract: A therapeutical method is disclosed for treating idiopathic asthenozoospermia which comprises orally or parenterally administering to a patient in need thereof a combination preparation comprising in admixture L-carnitine and acetyl L-carnitine or the pharmacologically acceptable salts thereof, in substantially equimolar amouts.
    Type: Application
    Filed: July 16, 2002
    Publication date: January 9, 2003
    Applicant: Sigma-Tau HealthScience S.p.A.
    Inventor: Claudio Cavazza
  • Treating chronic uremic patients undergoing periodical dialysis
    Publication number: 20020198263
    Abstract: The method for the treatment of chronic uremic patients undergoing periodical dialysis is useful for preventing and/or treating carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. The method according to the present invention comprises administering an effective dose of carnitine intravenously into the venous return line after each dialysis session.
    Type: Application
    Filed: July 8, 2002
    Publication date: December 26, 2002
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Food supplemented with a carnitine, suitable for stimulating the biosynthesis of polyunaturated fatty acids from the saturated fatty acids contained in the food
    Publication number: 20020192346
    Abstract: A food selected from the group comprising milk and dairy products derived from milk, comprising a carnitine in an effective amount to stimulate, through the natural fatty acid metabolic processes that take place in a consumer of said food, the synthesis of polyunsaturated fatty acids from the saturated fatty acids originally contained in the food.
    Type: Application
    Filed: June 3, 2002
    Publication date: December 19, 2002
    Inventor: Claudio Cavazza
  • Treating chronic uremic patients undergoing periodical dialysis
    Publication number: 20020138032
    Abstract: Chronic uremic patients undergoing periodical dialysis are treated with carnitine or one of its salts to prevent or treat carnitine deficiency in patients with end stage renal disease. An effective dose of carnitine, preferably L-carnitine fumarate, is administered preferably intravenously into the venous return line after each dialysis session.
    Type: Application
    Filed: March 13, 2002
    Publication date: September 26, 2002
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Treating chronic uremic patients undergoing periodical dialysis
    Patent number: 6429230
    Abstract: The method for the treatment chronic uremic patients undergoing periodical dialysis is useful for preventing and/or treating carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. The method according to the present invention comprises administering an effective dose of carnitine intravenously into the venous return line after each dialysis session.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: August 6, 2002
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Medicament and therapeutical method for treating idiopathic asthenozoospermia
    Publication number: 20020058632
    Abstract: A therapeutical method is disclosed for treating idiopathic asthenozoospermia which comprises orally or parenterally administering to a patient in need thereof a combination preparation comprising in admixture L-carnitine and acetyl L-carnitine or the pharmacologically acceptable salts thereof, in substantially equimolar amouts.
    Type: Application
    Filed: December 6, 2001
    Publication date: May 16, 2002
    Applicant: Sigma-Tau HealthScience S.p.A.
    Inventor: Claudio Cavazza
  • Treating chronic uremic patients undergoing periodical dialysis
    Publication number: 20020052415
    Abstract: The method for the treatment of chronic uremic patients undergoing periodical dialysis is useful for preventing and/or treating carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. The method according to the present invention comprises administering an effective dose of carnitine intravenously into the venous return line after each dialysis session.
    Type: Application
    Filed: October 5, 2001
    Publication date: May 2, 2002
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Process for the preparation of non-hygroscopic salts of L(?)-carnitine
    Patent number: 6372940
    Abstract: An improved process for the preparation of non-hygroscopic salts of L(−)-carnitine, in which the characterizing step comprises heating a mixture comprising L(−)-carnitine inner salt and a fumaric acid or tartaric acid.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: April 16, 2002
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
    Inventor: Claudio Cavazza
  • Antioxidant composition comprising acetyl L-carnitine and &agr;-lipoic acid
    Patent number: 6365622
    Abstract: A composition containing the active ingredients acetyl L-carnitine and &agr;-lipoic acid for the prevention and/or therapeutic treatment of various alterations and pathological states induced by free radicals, that may be in the form of a dietary supplement, dietetic support or of an actual medicine.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: April 2, 2002
    Assignee: Sigma-Tau HealthScience S.p.A.
    Inventor: Claudio Cavazza
  • Treating chronic uremic patients undergoing periodical dialysis
    Publication number: 20020028850
    Abstract: Chronic uremic patients undergoing periodical dialysis are treated with carnitine or one of its salts to prevent or treat carnitine deficiency in patients with end stage renal disease. An effective dose of carnitine, preferably L-carnitine fumarate, is administered preferably intravenously into the venous return line after each dialysis session.
    Type: Application
    Filed: August 14, 2001
    Publication date: March 7, 2002
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Method for treating celiac disease
    Patent number: 6348495
    Abstract: A method for treating celiac disease comprising administration of a composition containing an alkanoyl L-carnitine wherein the alkanoyl group is straight or branched and has 2-6 carbon atoms and the pharmacologically acceptable salts thereof.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: February 19, 2002
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Claudio Cavazza, Luigi Mosconi
  • Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-L-carnitine and hypericin
    Patent number: 6346282
    Abstract: This invention relates to a composition of acetyl-L-carnitine in combination with hypericin and/or Hypericum extract (Hypericum perforatum L. (St. John's Wort)) in synergistically effective amounts. The composition is effective at treating a nervous alteration due to an anxiety state, irritability, or depression.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: February 12, 2002
    Assignee: Sigma-Tau Healthscience S.p.A.
    Inventor: Claudio Cavazza
  • Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia
    Publication number: 20020002202
    Abstract: The invention described herein relates to the use of L-carnitine or one of its alkanoyl derivatives with formula (I) where R is an alkanoyl group with from 2 to 8 carbon atoms, and X− is the acid fumarate anion, for the preparation of a medicine useful in the treatment and prevention of organ ischemia.
    Type: Application
    Filed: May 17, 2001
    Publication date: January 3, 2002
    Inventors: Claudio Cavazza, Arduino Arduini
  • Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome
    Patent number: 6335038
    Abstract: A composition that may take the form of a dietary supplement or of a medicament is disclosed which comprises as active ingredients propionyl L-carnitine and the isoflavone genistein for the therapeutic treatment of osteoporosis and menopause syndrome.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: January 1, 2002
    Assignee: Sigma-Tau Healthscience S.p.A.
    Inventor: Claudio Cavazza
  • Treating chronic uremic patients undergoing periodical dialysis
    Patent number: 6335369
    Abstract: Chronic uremic patients undergoing periodical dialysis are treated with carnitine or one of its salts to prevent or treat carnitine deficiency in patients with end stage renal disease. An effective dose of carnitine, preferably L-carnitine fumarate, is administered preferably intravenously into the venous return line after each dialysis session.
    Type: Grant
    Filed: January 18, 2001
    Date of Patent: January 1, 2002
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Composition for controlling mood disorders in healthy individuals
    Patent number: 6335021
    Abstract: The use of acetyl L-carnitine and its pharmacologically acceptable salts is disclosed for producing a composition suitable for controlling mood disorders mainly in young individuals who are not affected by permanent pathological CNS disturbances.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: January 1, 2002
    Assignee: Sigma-Tau HealthScience S.p.A.
    Inventor: Claudio Cavazza
  • Composition comprising L-carnitine or an alkanoyl L-carnitine and long-chain alkanols
    Patent number: 6328998
    Abstract: The use of L-carnitine, some alkanoyl L-carnitines and the pharmacologically acceptable salts thereof in combination with long-chain alkanols such as polycosanols, or polycosanol-bearing natural products or extracts thereof for the prevention and treatment of diseases caused by abnormal lipid metabolism, such as atherosclerosis, hypercholesterolemia, cardiovascular disorders and peripheral diabetic neuropathy.
    Type: Grant
    Filed: January 3, 2000
    Date of Patent: December 11, 2001
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Pharmaceutical composition suitable for stimulating the multiplication and growth of osteoblasts
    Patent number: 6329358
    Abstract: A pharmaceutical composition consisting essentially of an alkanoul L-camitine wherein the alkanoyl group is linear or branched and as 2-8 carbon atoms, dehydroepiandrosterone or.dehydroepiandrosterone sulphate.
    Type: Grant
    Filed: October 8, 1999
    Date of Patent: December 11, 2001
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
    Inventor: Claudio Cavazza
  • Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
    Publication number: 20010044465
    Abstract: Alkanoyl L-carnitines of the formula: 1
    Type: Application
    Filed: January 26, 2001
    Publication date: November 22, 2001
    Inventors: Claudio Cavazza, Caudio Pisano, Loredana Vesci